Tadawul
Mouwasat Medical Services
4002.TADAWULSAR 66.15
+1.30%+0.85Tadawul
SAR 66.15
+1.30%+0.85Valuation, profitability, balance-sheet health, growth — with 5-year and industry averages.
| Metric | Company | 5Y avg | Industry avg |
|---|---|---|---|
| P/E (TTM) | 16.0 | 27.9 | 11.6 |
| Forward P/E | 13.7 | — | 10.4 |
| P/S | 4.02 | 6.82 | 3.89 |
| P/B | 3.32 | 5.57 | 1.40 |
| P/CF | 11.2 | 20.5 | 0.5 |
| P/FCF | 35.2 | 33.0 | -5.4 |
| EV / EBITDA | 12.4 | 22.6 | 20.9 |
| EV / Sales | 4.21 | 7.02 | 6.94 |
| EV / EBIT | 16.0 | 25.9 | 14.7 |
| PEG | — | — | — |
| Earnings yield | +6.24% | +3.94% | +9.73% |
| FCF yield | +2.84% | +3.69% | -4.25% |
| Dividend yield | +6.32% | — | +4.96% |
| Payout ratio | +72.6% | — | +46.9% |
| Metric | Company | 5Y avg | Industry avg |
|---|---|---|---|
| EPS (TTM) | 4.13 | 3.41 | 2.51 |
| Book value per share | 19.90 | 16.93 | 20.13 |
| FCF per share | 1.88 | 3.13 | -4.76 |
| Revenue per share | 16.46 | 13.93 | 11.41 |
| Metric | Company | 5Y avg | Industry avg |
|---|---|---|---|
| ROIC | +17.0% | +16.9% | +6.0% |
| ROE | +21.3% | +20.1% | +10.9% |
| ROA | +9.0% | +12.9% | +2.0% |
| Gross margin | +41.1% | +45.2% | +6.7% |
| Operating margin | +24.8% |
| Metric | Company | 5Y avg | Industry avg |
|---|---|---|---|
| Debt / Equity | 0.28 | 0.25 | 1.05 |
| Debt / Assets | +19.3% | +15.9% | +24.3% |
| Net debt / EBITDA | 0.59 | 0.65 | 5.29 |
| Current ratio | 1.62 | — | 1.20 |
| Quick ratio | 1.30 | — |
| Metric | Company | 5Y avg | Industry avg |
|---|---|---|---|
| Revenue growth (YoY) | +9.1% | +11.4% | +8.5% |
| EPS growth (YoY) | +27.3% | +11.7% | +21.4% |
| +49.0% |
| EBITDA margin | +34.0% | +31.0% | +3.4% |
| Net margin | +25.1% | +24.5% | +44.0% |
| FCF margin | +22.8% | +22.2% | -55.6% |
| Asset turnover | 0.55 | 0.53 | 0.15 |
| 0.88 |
| Cash ratio | 0.50 | 0.31 | 21.03 |
| Interest coverage | 44.5 | 28.2 | 141.2 |
| Equity ratio | +63.1% | +64.5% | +21.9% |